The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksH.k.land Regulatory News (HKLD)

Share Price Information for H.k.land (HKLD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.41
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 7.41
High: 0.00
Low: 0.00
Prev. Close: 7.41
HKLD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

21 Nov 2023 09:22

RNS Number : 1375U
Hongkong Land Hldgs Ltd
21 November 2023
 

Announcement

 

The following announcement was issued today to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

HONGKONG LAND ANNOUNCES NEW LEADERSHIP APPOINTMENT WITH MICHAEL SMITH TO SUCCEED ROBERT WONG AS CHIEF EXECUTIVE

 

21st November 2023 - Michael Smith has been appointed Chief Executive of Hongkong Land Holdings Limited with effect from 1st April 2024. He will succeed Robert Wong who has been the Chief Executive of Hongkong Land since 2016.

Michael is currently the Regional Chief Executive Officer of Europe and the US at Mapletree Investments, a global real estate development, investment, capital and property management company with over US$55 billion of assets under management, headquartered in Singapore.

During his nearly seven years at Mapletree, Michael has been responsible for growing the group's new and existing businesses in Europe and the US, and accountable for overall operating performance. Under Michael's leadership, the Europe and US portfolio has grown to account for over a third of the group's assets under management, across diversified asset classes including logistics, data centres, business parks and student housing. In addition to building scale, Michael has been responsible for monetising assets into public and private vehicles, while leading a large team of professionals across multiple jurisdictions.

Prior to joining Mapletree, Michael was a Partner at Goldman Sachs, and led the bank's Southeast Asia investment banking, as well as Asia Pacific (ex-Japan) real estate businesses. Altogether, Michael brings 30 years of real estate, capital markets and investment banking experience.

Ben Keswick, Chairman of Hongkong Land Holdings Limited, said, "I am delighted to welcome Michael to Hongkong Land. Michael brings a proven track record in real estate investment and capital allocation. He has grown organisations by being an inspirational and caring people leader. Building on Hongkong Land's pre-eminent capabilities, reputation and portfolio, I have every confidence Michael will evolve our business - ensuring we continue to invest, manage and develop prime commercial, retail and mixed-use assets, while at the same time, positioning the Group for long-term sustainable growth in China and other key Asian markets."

"I would like to thank Robert for his over 38 years of outstanding service to Hongkong Land. Robert has been instrumental to the development and execution of Hongkong Land's mainland China strategy since the early 1990s. As Chief Executive for the past seven years, Robert has enhanced the Group's Central portfolio in Hong Kong ensuring it remains the pre-eminent office, luxury retail, restaurant, and hotel accommodation destination in the heart of the city. He has also continued the Group's strategic focus to develop, grow and hold prime commercial and luxury retail properties, including the US$3.3 billion mixed-use investment in West Bund, Shanghai which is currently under development. Our strategic investments in mainland China will be integral to Hongkong Land's next phase of growth and value creation. Finally, Robert has led the charge to embed sustainability into the way in which we operate and make decisions at Hongkong Land."

Robert will retire from his role as Chief Executive on 31st March 2024. Robert will continue as a senior advisor to ensure a smooth leadership transition. Michael will relocate to Hong Kong with his wife and children.

Michael Smith has held a directorship in the following listed company in the past five years:

Mapletree Industrial Trust Management Ltd., as Manager of the Mapletree Industrial Trust

 

Non-Executive Director

15th December 2019 to date

No further information is required to be disclosed in respect of Michael Smith's appointment pursuant to 9.6.13R of the Listing Rules of the UK Listing Authority.

Hongkong Land is a major listed property investment, management and development group. The Group owns and manages more than 850,000 sq. m. of prime office and luxury retail assets in key Asian cities, principally Hong Kong, Singapore, Beijing and Jakarta. Its properties hold industry leading green building certifications and attract the world's foremost companies and luxury brands. The Group also has a number of high-quality residential, commercial and mixed-use projects under development in cities across China and Southeast Asia, including a 43% interest in a 1.1 million sq. m. mixed-use project in West Bund, Shanghai. Its subsidiary, MCL Land, is a well-established residential developer in Singapore.

 

Hongkong Land Holdings Limited is incorporated in Bermuda and has a primary listing in the standard segment of the London Stock Exchange, with secondary listings in Bermuda and Singapore. The Group's assets and investments are managed from Hong Kong by Hongkong Land Limited. Hongkong Land is a member of the Jardine Matheson Group.

 

 

- end -

 

 

For Media enquiries:

 

Hongkong Land

Jennifer Lam

(852) 2842 8222 / jennifer.lam@hkland.com

Louise Corbett

(852) 2842 8541 / louise.corbett@hkland.com

Ada Suen

(852) 2842 8262 / ada.suen@hkland.com

 

Brunswick Group Limited

William Brocklehurst

(852) 5685 9881

 

This and other Group announcements can be accessed through the Internet at 'www.hkland.com'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAZZMZMLMZGFZG
Date   Source Headline
22nd Apr 202410:24 amRNSUpdates on Executive Shareholdings by Management
17th Apr 202410:23 amRNSDirector/PDMR Shareholding
9th Apr 202410:27 amRNSAnnual Financial Report
14th Mar 20249:36 amRNSDirector/PDMR Shareholding
7th Mar 202411:01 amRNS2023 Preliminary Results
1st Mar 20249:22 amRNSCHANGE OF SINGAPORE BRANCH REGISTRAR
19th Jan 202410:44 amRNSDirector/PDMR Shareholding
30th Nov 202311:04 amRNSTotal Voting Rights
24th Nov 20239:22 amRNSDirectorate Change
21st Nov 20239:22 amRNSDirectorate Change
14th Nov 202310:44 amRNSTransaction in Own Shares
9th Nov 20239:52 amRNSINTERIM MANAGEMENT STATEMENT
2nd Nov 202310:57 amRNSTransaction in Own Shares
2nd Nov 202310:56 amRNSDirector/PDMR Shareholding
1st Nov 202310:33 amRNSTransaction in Own Shares
31st Oct 202311:47 amRNSTransaction in Own Shares
31st Oct 202311:46 amRNSTotal Voting Rights
29th Sep 202311:28 amRNSTotal Voting Rights
28th Sep 202311:32 amRNSTransaction in Own Shares
27th Sep 202311:43 amRNSTransaction in Own Shares
27th Sep 202310:26 amRNSDividend Declaration
27th Sep 20237:28 amRNSTransaction in Own Shares
18th Sep 202311:36 amRNSTransaction in Own Shares
15th Sep 20237:00 amRNSTransaction in Own Shares
11th Sep 20231:34 pmRNSTransaction in Own Shares
31st Aug 202311:54 amRNSTransaction in Own Shares
31st Aug 202311:54 amRNSTotal Voting Rights
29th Aug 20237:00 amRNSTransaction in Own Shares
25th Aug 202311:27 amRNSTransaction in Own Shares
24th Aug 202311:50 amRNSTransaction in Own Shares
23rd Aug 202312:20 pmRNSTransaction in Own Shares
31st Jul 202312:31 pmRNSTotal Voting Rights
31st Jul 202312:25 pmRNSTransaction in Own Shares
28th Jul 202310:40 amRNSHalf-year Results
28th Jun 202311:20 amRNSDirector/PDMR Shareholding
18th May 202310:22 amRNSInterim Management Statement
16th May 202310:41 amRNSDirector/PDMR Shareholding
9th May 202310:20 amRNSDirectorate Change
4th May 202312:49 pmRNSResult of AGM
28th Apr 202311:30 amRNSTotal Voting Rights
26th Apr 202310:38 amRNSDividend Declaration
20th Apr 202311:43 amRNSDirector/PDMR Shareholding
18th Apr 202311:46 amRNSTransaction in Own Shares
17th Apr 202312:34 pmRNSTransaction in Own Shares
14th Apr 20237:00 amRNSTransaction in Own Shares
11th Apr 20231:43 pmRNSTransaction in Own Shares
6th Apr 20237:00 amRNSTransaction in Own Shares
3rd Apr 202311:50 amRNSTransaction in Own Shares
3rd Apr 202310:25 amRNSAnnual Financial Report
31st Mar 202311:57 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.